AP NEWS

Global Cytology Market Report 2018 - Forecast to 2022 - ResearchAndMarkets.com

December 19, 2018

DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Global Cytology Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The cytology market will register a CAGR of nearly 7% by 2022.

The screening of cervical cancer has reduced the morbidity and mortality drastically. The Pap test is used as a screening tools for cervical cancer has improved detection of cervical intraepithelial neoplasia. Furthermore, increasing prevalence of HPV-associated cancers is likely to drive the market. Therefore, a substantial increase of HPV-associated cancers propels the demand for cytology testing and screenings methods. Furthermore, co-testing helps manage women who have low grade abnormal cell changes.

Market Overview

Growing cervical cancer screening awareness

Cervical cancer is the most common in developing as well as developing countries. It is mainly caused by human papillomavirus infection. Screening of cervical cancerous cells in mainly done by using liquid-based cytology test and Pap smear test. The increasing prevalence of cervical cancer cases have increased the demand for cytology testing.

Factors affecting adequacy of test

Poor fixation, techniques, inflammatory changes, and cellular changes related to radiation may obscure cells and cause misinterpretation of the result. This had led to false positive diagnostics which can occur in case of pregnancy, contamination of the sample, and others. Such factors will affect the adequacy of the test result and hence negatively affect the market.

Competitive Landscape

The global cytology market is extremely concentrated with the presence of few companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the markets competitive landscape and offering information on the products offered by companies.

Report Summary:

The latest trend gaining momentum in the market is the increasing awareness and screening initiatives for HPV co-testing and benefits of early diagnostics of the disease are likely to increase the demand for cytology testing marketing.

According to the report, one of the major drivers for this market is the growing preference for liquid-based cytology tests. Further, the report states that one of the major factors hindering the growth of this market is air dying artefacts, diagnostic pitfalls and false negatively results that affect the overall adequacy of the test, thus negatively impacting the market growth.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 05: MARKET SIZING

Market sizing 2017 Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY PRODUCT

Assay kits Systems

PART 09: MARKET SEGMENTATION BY END-USER

Comparison by end-user Hospitals and clinics Research laboratories and academic institutes Others Market opportunity by end-user

PART 10: REGIONAL LANDSCAPE

Geographical segmentation mainly was the word Regional comparison Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

Growing popularity of co-testing Consolidation and automation of laboratories Advent of cytology imaging systems

PART 14: VENDOR LANDSCAPE

Landscape disruption

PART 15: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Abbott BD F. Hoffmann-La Roche Hologic Thermo Fisher Scientific Trivitron Healthcare

For more information about this report visit https://www.researchandmarkets.com/research/977gj8/global_cytology?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005657/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:In Vitro Diagnostics

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH OTHER SCIENCE SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/19/2018 01:01 PM/DISC: 12/19/2018 01:01 PM

http://www.businesswire.com/news/home/20181219005657/en

AP RADIO
Update hourly